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ABSTRACT: DNA methylation is an epigenetic modification known to affect gene expression, cel-
lular differentiation, as well as phenotypes. Recent advancements in next-generation sequencing
technologies have provided unparalleled insight into the location and function of DNA methylation
in a variety of organisms. These data require vastly different statistical procedures than data from
previous genomic-based technologies. We outline the biological and chemical processes involved in
several approaches for gaining DNA methylation data. The implications of the differences between
the approaches are discussed relative to the statistical methodology, and the use of genome anno-
tation is explored for the purpose of improving the statistical power when testing for differential
methylation.
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Epigenetics is broadly defined as the study of heritable changes in physical characteristics of organ-
isms that are not attributable to changes in the DNA sequence. There are two key areas of focus
in epigenetics, namely histone modifications and DNA methylation (herein referred to as methyla-
tion). The study of histone modifications primarily addresses how DNA coils and uncoils itself in
a cell’s nucleus when transitioning from active and inactive transcription states. This type of epi-
genetic modification is not a direct modification to the DNA sequence. Methylation, on the other
hand, involves the attachment of methyl groups typically to cytosine bases, which directly affects
how the cell’s infrastructure behaves during transcription (Figure 1). Methylation abundance has
been associated with silencing gene expression (Figure 2) (Aoyama et al., 2004; Finnegan, 2010),
and promoting the occurrence of cancer (Feinberg and Vogelstein, 1983; Kouzarides, 2002).
Methylation studies that examine the entire genome have become increasingly prevalent in the
literature (Wang et al., 2006; Irizarry et al., 2008; Cokus et al., 2008; Lister et al., 2008, 2009; Bock
et al., 2010). Using next-generation sequencing (NGS) technologies, it is now possible to interro-
gate the epigenome at single-base detail (or single-base ‘resolution’). This is providing unparalleled
insight into the role and function of DNA methylation in a variety of organisms. While the ad-
vancement of NGS has moved epigenetics forward, the diversity of the technologies has presented
new challenges. Luckily, the major NGS technologies follow a similar workflow (Figure 3). Specifi-
cally, DNA is sampled, broken into fragments which are selected for size, and then sequenced. The
resulting sequences are then compared to, and placed on (i.e., aligned to), a fully sequenced genome
(referred to as a ‘reference genome’). The occurrence of an observed nucleotide, at a specific posi-
tion relative to the reference genome, is counted (this is referred to as ‘sequencing depth’ or simply
‘depth’). The proportion of the entire genome covered by at least one base (or, at a designated
depth) is referred to as ‘coverage.’ The most popular goal for NGS count data are applications of
in genomics. They have promoted many novel applications of statistical techniques, ranging from
Fisher’s Exact Test (Lister et al., 2008) to Bayesian deconvolution methods (Down et al., 2008).
The cost and efficacy of current NGS technologies for whole-genome methylation analysis are dis-
cussed in detail in Harris et al. (2010) and Bock et al. (2010), where each method is applied to
human embryonic stem cells in an effort to compare cost, detection levels, and concordance among
the techniques. We review the biological and chemical properties of these methods, and how these
properties affect the statistical procedures that both summarize and test differential methylation be-
tween samples or treatments. In an effort to improve on existing statistical approaches, we explore
the concept of incorporating of genome annotation into the statistical analysis. This additional
information serves to increase interpretability of testing results, and also improves the statistical
power to detect small changes in methylation levels.
2 Immunoprecipitation-Based Technologies
One major class of technologies for analyzing DNA methylation using NGS is immunoprecipitation-
based approaches. These methods utilize antibodies to select only DNA fragments which exhibit
cytosine methylation. Two algorithms, “MBD-isolated Genome Sequencing” (MiGS) (Serre et al.,
2010) and “Bayesian tool for methylation analysis” (Batman) (Down et al., 2008), are popular tools
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Figure 1: Primary components of epigenetics. DNA is tightly wound around nucleosomes, that
are octamers of histones. Modifications to histone tails affect how DNA coils and uncoils around
the nucleosomes. DNA methylation typically occurs at cytosine sites, and is known to affect
transcription(Groom et al., 2010).
for the analysis of methylation data. Both methods are restricted to CG (i.e., a cytosine followed
by a guanine base) methylation contexts (i.e., these methods ignore other possible contexts) and
accuracy to within 100 bases. The base pair coverage across the genome for these two approaches
are similar as well (∼65% coverage at 1 read threshold, ∼25% coverage at 5 reads threshold, for
each approach) (Beck, 2010).
The MiGS procedure uses a methyl CG binding domain protein called MBD2 to precipitate (i.e.,
capture) methylated DNA fragments after they are broken into pieces. As the frequency of methy-
lation increases for a particular fragment, the likelihood that it is captured also increases. This
procedure guards against over-representation of fragments showing intermittent methylation. Once
captured, the MBD2 proteins are stripped and the fragments are sequenced via a NGS platform and
aligned to a reference genome (Figure 6). While the size of the fragments is platform-dependent,
the average number of bases actually sequenced is generally much lower than the overall fragment
length. For example, the average fragment length for the Illumina GAII platform in Serre et al.
(2010) was 120 bp, while the average sequence length was 36 bp.
The discrepancy between average fragment length and average sequence length is important since
only the approximately 36 bases actually sequenced are used to align the read information to a
reference genome, even though methylation can occur at any CG dinucleotide in the entire fragment.
To overcome this limitation, Serre (Serre et al., 2010) suggests three steps. First, the entire reference
genome can be divided into non-overlapping 100-bp bins. After aligning the reads to the reference
genome, the start and end position of each of the reads are recorded. As these reads represent the
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Figure 2: DNA methylation and phenotype. Genetically identical Arabidopsis plants, differing only
in methylation levels at the fwa-1 locus, exhibit vastly different flowering times when grown under
similar conditions(Jacobsen, 2011).
position of an entire fragment, the coverage of each read is extended to the average fragment length
(e.g., 120 bp). Each extended read is then assigned to the genomic bin that it most covers. In this
fashion, 100-bp resolution is achieved, and non-empty genomic bins indicate putative methylation
sites. After correcting for the total number of unique reads mapped in each treatment, testing
for differential methylation is typically achieved via a Fisher’s Exact Test (Fisher, 1922) with the
observed number of reads for two treatments in each window (see Table 1).
Bin Index Treatment 1 Treatment 2
1 n11 n12
2 n21 n22
· · · · · · · · ·
N nN1 nN2
Table 1: Contingency table for bin level Fisher’s Exact Test used in MiGS.
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Figure 3: General workflow for next-generation sequencing whole-genome methylation technologies.
The workflows differ primarily with respect to method-specific chemical compounds (blue box step).
These differences are highlighted in Figure 4.
The Batman algorithm was designed specifically for methylated DNA immunoprecipitation (MeDIP)
based experiments. Unlike the MBD2 protein used in the MiGS procedure, the monoclonal anti-
bodies used in MeDIP procedures (for details, see (Weber et al., 2005)) do not distinguish between
regions of sparse or dense CG methylation. This leads to increased coverage at the cost of po-
tentially inflating the influence of sparsely methylated regions. Once captured, the antibodies are
removed and the fragments are sequenced.
To address the problems associated with sporadic methylation, the Batman algorithm models the
effects of the density of methylated CGs. Specifically, let D be the sequencing data, summarized
to coverage (i.e., sequencing depth) at each base pair. The the sequencing depth is denoted Dr
at read position r. A function of the distance between r and a given CG dinucleotide c, is called
the coupling factor Ccr. Let mc denote the methylation state at CG c, and let the set of all
methylation states be defined as m. The Batman algorithm defines the probability distribution for
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Attach sequence adapters and sequence
Figure 4: Primary differences in workflow for next-generation sequencing whole-genome methyla-
tion studies. Immunoprecipitation-based studies (MBD and MeDIP) only select fragments where
methylation is present, without any direct modification to the base sequence. Bisulfite-based meth-
ods (RRBS and MethylC) convert unmethylated cytosines to uracils, that become thymines during
PCR. These methods retain fragments indiscriminately of methylation presence, contrary to the
immunoprecipitation methods.








where G′ represents a truncated (at 0) Gaussian probability density function, ρ is a polynomial
function of order two, and v−1 is an estimate of the inverse variance of D around its mean. To ease
the computational time of the algorithm, CG dinucleotides are grouped in 100-bp bins and f(m|D)
is subsequently estimated using nested sampling (Skilling, 2006).
Since MeDIP selects fragments showing any methylation, each CG pair on an observed read are
typically given greater probability of methylation, regardless of whether the read was fully methy-
lated or only had one methylated CG site. Under the Batman model, the probability of methylation
for a given CG dinucleotide depends on the number of methylated CGs on the read via the coupling
factor Ccr, or, more generally, the total coupling for the read Ctot =
∑
cCcr. As the density of
methylation increases around a given CG dinucleotide, this composite factor Ctot gives additional
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Figure 5: Illustration of data produced by MBD2 (used in MiGS) or MeDIP (used in Batman)
sequencing. Sequencing reads are mapped (with direction) to a reference genome. Reads are
observed only when methylation is present within the sequence fragment.
weight to the probability that the given site is methylated. In adjusting for methylation density in
this way, the Batman algorithm attempts to remove some of the bias associated with the fragment
selection procedures associated with MeDIP. This correction is most apparent in applications with
long reads and sparse methylation.
3 Bisulfite-Based Technologies
Another major class of technologies used for examining DNA methylation in NGS employ a sodium
bisulfite treatment step, which converts unmethylated cytosines to uracils (Figure 4). The two most
common approaches are Reduced Representation Bisulfite Sequencing (RRBS, (Meissner et al.,
2005)) and MethylC-seq (Lister et al., 2008). Unlike immunoprecipitation-based technologies,
bisulfite-based technologies are able to interrogate the methylome at single base-pair resolution
(Figure 6). Higher resolution comes at a price, though, since either genomic coverage (RRBS,
∼10% coverage genome-wide), or cost (MethylC-Seq, ∼5- to 10-fold increase in cost over other
methods) is sacrificed.
The reduction in coverage when using RRBS is attributed to the preprocessing steps of the DNA
sample. Sample DNA is digested using a restriction endonuclease enzyme, which cuts the DNA
at specific locations based on the underlying nucleotide sequence. The resulting fragments are
7




Figure 6: Illustration of data produced by Reduced Representation Bisulfite Sequencing (RRBS), or
MethylC-seq. Sequencing reads are mapped (with direction) to a reference genome and methylation
status is observed (green circles). Reads are observed independently of methylation status.
then size-selected and treated with sodium bisulfite. The process of digestion and size selection
generates predictable fragments based on prior knowledge of the DNA sequence being studied,
and as such, a “reduced representation” of the genome (generally 10-12%) is generated. The
bisulfite treatment converts unmethylated cytosines to uracils, but is quite damaging to the sample
product. The lengthy digestion process degrades almost the entire sample (>90% degradation
within the first hour of bisulfite treatments (Grunau et al., 2001)). With this in mind, the bisulfite-
treated samples are amplified through polymerase chain reaction (PCR) in excess of 8 times before
sequencing. Sequenced fragments are then compared against reference fragments which have been
computationally derived given the genome sequence and restriction enzyme sequence digestion
proclivity. This process tends to bias toward CG-rich regions in the genome, limiting the scope of
RRBS studies (Beck, 2010).
Rather than using a restriction enzyme to fragment the genome, the current gold-standard for
NGS methylation studies, MethylC-seq, subjects the sample DNA to high-frequency sound waves,
called sonication, producing fragments that cover the entire genome with no sequence bias. These
fragments are then size-selected, amplified through PCR, and sequenced. Since fragments can theo-
retically originate from any location in the genome, sequenced reads are aligned to the entire genome
sequence (rather than the reduced genome used in RRBS). This feature requires considerably more
sample DNA than does RRBS (5µg vs. 0.03-0.05µg for MethylC-seq and RRBS, respectively (Beck,
2010)).
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Cytosine Index 1 2 · · · K Subset Total
Treatment 1
Rep. 3 17/19 (M) 3/17 (UM) · · · 13/16 (M) ⇒ 47/50
Rep. 2 7/20 (UM) 13/13 (M) · · · 11/15 (M) ⇒ 15/50
Rep. 1 3/5 (M) 1/14 (UM) · · · 14/19 (M) ⇒ 42/50
Treatment 2
Rep. 1 1/15 (UM) 13/14 (M) · · · 8/16 (M) ⇒
Rep. 2 2/17 (UM) 1/17 (UM) · · · 7/11 (M) ⇒
Rep. 3 3/11 (UM) 2/15 (UM) · · · 13/17 (M) ⇒
⇓ ⇓ ⇓ ⇓
Base Pair Decision D ND · · · ND
Table 2: For each cytosine (in CG context) and replicate, the number of reads indicating methyla-
tion out of the sequencing depth (total number of reads mapped to the cytosine) are recorded. Tests
for differential methylation can be performed with base-pair level testing (in blue, D=”Differentially
Methylated” and ND=”Not Differentially Methylated”).
Both methods, RRBS and MethylC-seq, produce several (5-15, on average) reads at each genomic
cytosine at which the methylation status is also recorded. These data (Table 2) can be summarized
between treatments in a number of ways. Meissner et al. (2005) summarized RRBS data by
calculating the correlation between the read profile for wild-type and two methylation maintenance
deprived mutant lines. Lister et al. (2008), on the other hand, took a testing approach. Specifically,
for each cytosine to which unique reads aligned, a Fisher’s Exact Test was performed (Table 3).
Once completed for each cytosine, these results were summarized over 1000bp windows. If the
proportion of differentially methylated cytosines exceeded a pre-specified threshold (say, 20%),
which is determined in an ad hoc manner, the window was labeled differentially methylated (DM),
and neighboring DM windows were combined to form a differentially methylated region (DMR).
4 Incorporating Annotation
While NGS technologies have allowed researchers to gain valuable insight into epigenomics, the in-
clusion of other information that is available in well-annotated databases has not been investigated.
In addition to the sequence of bases which make up DNA, and the methylation information, the
genomes of many species are well-documented or well-annotated, meaning that there are data for
the genomic location and function of genes, as well as other intergenic regions. The annotation
information not only provides information as to what the base sequence is, but it also includes
the genomic context of the sequence (e.g., exon, intron, untranslated region, etc.). Annotation
information is generally only used after an analysis is performed, and for the purpose of bringing
scientific context to the investigation. Specifically, once the single bin (for immunoprecipitation-
based technologies) or single base (for bisulfite-based technologies) tests have been performed, and
statistically significant results determined, only then is the annotation information brought to the
biological interpretation of the results. Interestingly, Zhang et al. (2006) showed that methylation
patterns can vary greatly between annotated regions, information that indeed may be useful. In
fact, testing within annotation regions has several advantages when compared to the traditional
sliding window approaches (Lister et al., 2008, 2009). First, the individual base or bin tests are
9




Cytosine Treatment 1 Treatment 2
Unmethylated reads n11 n12
Methylated reads n21 n22
Table 3: 2× 2 contingency table for base-pair level Fisher’s Exact Test.
likely to be more homogeneous in a single annotated region than in a window which may include
multiple annotated regions. Secondly, conclusions drawn from annotated regions are generally more
interpretable than those gained from windows. Testing over annotated regions offers an attractive
way to incorporate preexisting biological knowledge. It has potential for a significant impact on
both the analysis and the interpretation of results.
We incorporate annotation early in the analysis pipeline using a subset-level test. The read informa-
tion at each cytosine is summarized into a binary representation (i.e., methylated or unmethylated)
for each sample using a predetermined threshold (typically 50%). These summaries are then com-
pared using a Fisher’s Exact Test (in the case of single replicates within each treatment) or a logistic
regression (multiple replicates). Summarizing and testing in this fashion generally utilizes longer
gene lengths (in comparison to sequencing depth) when performing the statistical test, giving rise
to increased information and increased statistical power at equal or lower depths.
5 Simulation Study
Although NGS technologies have ignited DNA methylation research, it is difficult to understand
the efficacy of each statistical method that has been used to analyze the data without extensive,
and costly, biological confirmation studies. As an alternative, we rely on simulations to explore
the strengths of each statistical approach. To expand upon the idea of subset-level testing, we
simulated 1000 exons under two treatments and explored the differences between two testing strate-
gies: single-base tests with post-hoc exon summaries (called ‘base-pair level tests’), and single-base
binary summaries with subsequent single tests over exons (called ‘subset-level tests’). Both dif-
ferentially methylated and non-differentially methylated exons were simulated such that, for each
exon, the known or true methylation status was generated independently for both treatments using
a Bernoulli distribution with p = .5. Exon lengths (in CG pairs) were simulated via a Poisson
distribution, with mean 20, 35, or 50; lengths are equal between treatments for each exon. Exon
lengths were chosen to represent a spectrum of overall gene lengths, with emphasis on shorter
genes. Within each exon, cytosine methylation was generated via a Hidden Markov Model, with
transition matrices (Table 4a). Sequencing depth was simulated using a Poisson (with mean 15,
the current average sequencing depth attained in literature) distribution. Finally, read methylation
was simulated through a Binomial(n = depth, p) distribution, where p is as described in Table 4b.
These parameters were chosen to reflect the averages and ranges of parameters commonly seen in
Arabidopsis and human DNA methylation studies (Lister et al., 2008, 2009).
Base-pair level and subset-level tests were performed using either a Fisher’s Exact Test (with one
replicate) or with a logistic regression(with three replicates). Currently next-generation sequencing
procedures are costly when compared to older technologies (i.e., microarrays); therefore, the number
of biological samples are typically limited (i.e., fewer than three). As such, the sample sizes (n=1
10














Table 4: Setup for Hidden Markov Model (HMM) simulation of exons. (a) HMM transition matrix
for methylated exons. This process is weighted toward the methylated cytosine (MC) state over
the unmethylated cytosine (UMC) to accurately reflect the underlying biological processes. The
transition matrix for unmethylated exons is constructed similarly. (b) Binomial probabilities of a
methylated read (MR) given cytosine methylation status (unmethylated (UMC) and methylated
(MC)).
and 3) chosen in this simulation study represent current practices. Multiple testing correction
was performed by controlling the false discovery rate (FDR)(Benjamini and Hochberg, 1995) at
α = 0.05. The simulation process was repeated 1000 times, and the statistical power of each
method was recorded (Figure 7).
As expected, increasing the number of replicates from one to three tends to improve the power of the
tests, with this trend being more evident in the single base-pair (BP) approach. When restricted to
a single replicate, the characteristics of individual cytosine methylation behavior (Figure 7 columns)
have little effect on the power of the subset-level testing approach. That is, as the consistency of read
methylation status given cytosine methylation status improves, little to no increase in statistical
power is observed. This may imply that for single-replicate exploratory experiments, the subset-
level approach will retain power more consistently as the levels of noise increase simply because the
subset summaries provide more information. Specifically, subsetting based on annotation allows
for testing even when the number of replicates is extremely low. The simulations presented here
can be extended for use with the immunoprecipitation-based technologies, replacing cytosines with
bins (with appropriate simulation modifications).
6 Conclusion
We have discussed several of the most commonly used approaches for exploring methylomes using
next-generation sequencing technologies. Since each experimental protocol differs slightly, differ-
ent statistical approaches are needed to model and test for differential methylation. While the
immunoprecipitation-based approaches (using the MiGS, or Batman algorithms) offer researchers
an inexpensive way to explore the methylome, the bisulfite-based methods (RRBS and MethylC-
seq) offer single-base resolution that proves to be beneficial for many epigenomic applications. Each
of these methods, however, require careful specification of the regions on which statistical tests for
differential methylation are applied. Defining these windows using annotation information can lead
to more homogeneous, powerful tests, even in unreplicated settings. We anticipate as the technolo-
gies for sequencing advance into single-molecule frameworks that the strategies presented here for
informing tests through annotation will easily translate and will be directly applicable to the new
data.
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One Replicate Three Replicates
Figure 7: Power analysis results for base-pair and subset focused testing procedures with one
(blue) or three (red) replicates with constant 5% false discovery rate. Power increases as exon
length increases and as binomial probabilities separate. The base-pair focused method benefits
more from replication than does the subset focused method, and has high performance in each
of the settings examined where replication was available. Each method performs well when the
binomial probabilities are well-separated. Performance of each method decreases as the HMM
transition matrices become less stable (not shown).
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